Hormones

"Hormones" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.

Descriptor ID	D006728
MeSH Number(s)	D06.472 D27.505.696.399.472
Concept/Terms	Hormones Hormones Hormone Hormone Receptor Agonists Hormone Receptor Agonists Agonists, Hormone Receptor Receptor Agonists, Hormone

Below are MeSH descriptors whose meaning is more general than "Hormones".

Chemicals and Drugs [D]
Hormones, Hormone Substitutes, and Hormone Antagonists [D06]
Hormones [D06.472]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Hormones, Hormone Substitutes, and Hormone Antagonists [D27.505.696.399]
Hormones [D27.505.696.399.472]

Below are MeSH descriptors whose meaning is related to "Hormones".

Below are MeSH descriptors whose meaning is more specific than "Hormones".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hormones" by people in this website by year, and whether "Hormones" was a major or minor topic of these publications.

Bar chart showing 142 publications over 30 distinct years, with a maximum of 9 publications in 2003

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1992	3	3	6
1993	3	1	4
1994	2	4	6
1995	1	1	2
1996	1	2	3
1997	3	2	5
1998	3	0	3
1999	0	1	1
2000	2	4	6
2001	2	3	5
2002	2	3	5
2003	3	6	9
2004	2	6	8
2005	2	4	6
2006	0	1	1
2007	3	3	6
2008	1	6	7
2009	2	2	4
2010	1	4	5
2011	2	2	4
2012	2	2	4
2013	2	2	4
2014	0	3	3
2015	5	1	6
2016	3	3	6
2017	4	1	5
2018	0	5	5
2019	2	2	4
2020	2	4	6
2021	1	2	3

Below are the most recent publications written about "Hormones" by people in Profiles.

Basu B, Jain M, Chopra AR. Caudamins, a new subclass of protein hormones. Trends Endocrinol Metab. 2021 12; 32(12):1007-1014.

View in: PubMed
Schneider F, Wistuba J, Holterhus PM, Kulle A, Schlatt S, Kliesch S, Neuhaus N, Zitzmann M. New Insights Into Extended Steroid Hormone Profiles in Transwomen in a Multi-Center Setting in Germany. J Sex Med. 2021 10; 18(10):1807-1817.

View in: PubMed
Du L, Yau C, Brown-Swigart L, Gould R, Krings G, Hirst GL, Bedrosian I, Layman RM, Carter JM, Klein M, Venters S, Shad S, van der Noordaa M, Chien AJ, Haddad T, Isaacs C, Pusztai L, Albain K, Nanda R, Tripathy D, Liu MC, Boughey J, Schwab R, Hylton N, DeMichele A, Perlmutter J, Yee D, Berry D, Van't Veer L, Valero V, Esserman LJ, Symmans WF. Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer before chemo-endocrine therapy. Ann Oncol. 2021 05; 32(5):642-651.

View in: PubMed
Abderrahman B, Maximov PY, Curpan RF, Fanning SW, Hanspal JS, Fan P, Foulds CE, Chen Y, Malovannaya A, Jain A, Xiong R, Greene GL, Tonetti DA, Thatcher GRJ, Jordan VC. Rapid Induction of the Unfolded Protein Response and Apoptosis by Estrogen Mimic TTC-352 for the Treatment of Endocrine-Resistant Breast Cancer. Mol Cancer Ther. 2021 01; 20(1):11-25.

View in: PubMed
Wetendorf M, Li R, Wu SP, Liu J, Creighton CJ, Wang T, Janardhan KS, Willson CJ, Lanz RB, Murphy BD, Lydon JP, DeMayo FJ. Constitutive expression of progesterone receptor isoforms promotes the development of hormone-dependent ovarian neoplasms. Sci Signal. 2020 10 06; 13(652).

View in: PubMed
Schettini F, Sobhani N, Ianza A, Triulzi T, Molteni A, Lazzari MC, Strina C, Milani M, Corona SP, Sirico M, Bernocchi O, Giudici F, Cappelletti MR, Ciruelos E, Jerusalem G, Loi S, Fox SB, Generali D. Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study. Breast Cancer Res Treat. 2020 Nov; 184(2):421-431.

View in: PubMed
Boone S. Man With Light-headedness and Near Syncope. Ann Emerg Med. 2020 08; 76(2):e9-e10.

View in: PubMed
Chainitikun S, Long JP, Rodriguez-Bautista R, Iwase T, Tripathy D, Fujii T, Ueno NT. The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. Breast Cancer Res Treat. 2020 Oct; 183(3):729-739.

View in: PubMed
Landua JD, Moraes R, Carpenter EM, Lewis MT. Hoxd10 Is Required Systemically for Secretory Activation in Lactation and Interacts Genetically with Hoxd9. J Mammary Gland Biol Neoplasia. 2020 06; 25(2):145-162.

View in: PubMed
Kelleher AM, DeMayo FJ, Spencer TE. Uterine Glands: Developmental Biology and Functional Roles in Pregnancy. Endocr Rev. 2019 10 01; 40(5):1424-1445.

View in: PubMed

People

Explore

Similar Concepts

Top Journals